Stay updated on Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.

Latest updates to the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s interface/version indicator was updated from revision v3.5.2 to v3.5.3, reflecting a maintenance or UI release rather than a change to the trial record itself.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision: v3.5.2 was added to the history. Revision: v3.5.0 was removed from the history.SummaryDifference0.1%

- Check36 days agoChange DetectedNew results have been posted, and the Outcomes Measures, Results, and Study Status sections have been updated.SummaryDifference0.4%

- Check51 days agoChange DetectedAdded Revision: v3.5.0 to the record history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a new site revision entry v3.4.3 and removed the previous v3.4.2 entry from the history.SummaryDifference0.1%

- Check79 days agoChange DetectedA new version entry dated 2026-02-13 was added, with QC status 'Has Not Concluded', and the record history now displays additional sections such as Adverse Events, Outcome Measures, Baseline Characteristics, and Participant Flow.SummaryDifference0.9%

Stay in the know with updates to Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.